Literature DB >> 16167549

Selective stroke of the solitary tract nuclei in two cases of central sleep apnoea.

A Parenti1, V Macchi, R Snenghi, A Porzionato, T Scaravilli, S D Ferrara, R De Caro.   

Abstract

Central sleep apnoea (CSA) is a breathing disorder characterized by repetitive central apnoeas with hypoxia interrupted by hyperventilation phases. In the literature, there are reports of CSA caused by brainstem infarcts. We report two patients (38 and 53 years old) with longstanding history of central sleep apnoea who died during sleep. In both cases the autopsy revealed acute bilateral hypoxic lesions at the level of the solitary tract nuclei. In one case, symmetrical selective neuronal necrosis was found in the dorsal part of the solitary tract nuclei. A chronic obstructive vasculopathy was also found, with thickening and fibrosis of the smallest vessels of the medullary tegmentum. In the other case, bilateral infarctions were found with the base at the ependymal lining of the 4th ventricle floor and the apex towards the solitary tract. An acute intramural hemorrhagic lesion in the premedullary segment of the left vertebral artery was also found. Episodes of hypoxemic hypoxia during sleep may worsen the effects of focal oligohemic hypoxia in the medullary tegmentum. Selective stroke of the solitary tract nuclei may be the acute fatal lesion in patients with both central sleep apnoea and lesions of the vertebro-basilar system. To the best of our knowledge, this is the first neuropathologic report of acute medullary ischemic-hypoxic lesions which may not be considered the cause of the CSA because of their recent onset. Our findings suggest that CSA, besides being caused by ischemic events at the level of the medulla, may also contribute to pathogenesis of strokes, through hypoxia or hemodynamic oscillations.

Entities:  

Mesh:

Year:  2005        PMID: 16167549

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  8 in total

1.  Interfacing pathophysiology of respiratory sleep disorders, cardiac dysfunction, and focal autonomic medullary brain ischemia.

Authors:  J Howard Jaster
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Reperfusion injury to ischemic medullary brain nuclei after stopping continuous positive airway pressure-induced CO2-reduced vasoconstriction in sleep apnea.

Authors:  J Howard Jaster
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Undiagnosed sleep-related breathing disorders are associated with focal brainstem atrophy in the elderly.

Authors:  Sébastien Celle; Roland Peyron; Isabelle Faillenot; Vincent Pichot; Majed Alabdullah; Jean-Michel Gaspoz; Bernard Laurent; Jean-Claude Barthélémy; Frédéric Roche
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

Review 4.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

Review 5.  The brainstem and serotonin in the sudden infant death syndrome.

Authors:  Hannah C Kinney; George B Richerson; Susan M Dymecki; Robert A Darnall; Eugene E Nattie
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

6.  Anatomic distribution of apoptosis in medulla oblongata of infants and adults.

Authors:  A Porzionato; V Macchi; D Guidolin; G Sarasin; A Parenti; R De Caro
Journal:  J Anat       Date:  2007-12-10       Impact factor: 2.610

7.  Proposed toxic and hypoxic impairment of a brainstem locus in autism.

Authors:  Woody R McGinnis; Tapan Audhya; Stephen M Edelson
Journal:  Int J Environ Res Public Health       Date:  2013-12-11       Impact factor: 3.390

8.  Brainstem involvement as a cause of central sleep apnea: pattern of microstructural cerebral damage in patients with cerebral microangiopathy.

Authors:  Thomas Duning; Michael Deppe; Eva Brand; Jörg Stypmann; Charlotte Becht; Anna Heidbreder; Peter Young
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.